Skip to main content

Table 4 Stepward forward regression analysis of lumbar BMD and metabolic parameters (A); stepward forward regression analysis of pyrilinks and BMD and metabolic variables (B)

From: Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus

A: Dependent variable L-BMD Beta p B: Dependent variable Pyrilinks Beta p
Age (years) 0,716 0,0002    
Menopause duration (years) −0,718 0,016    
BMI (kg/m2) 0,279 0,0021   0,309 0,053
Waist circumference (cm)     −0,381 0,011
Triglycerides (mmol/L)      
Insulin (mIU/L) −0,273 0,009    
PAI-1(U/l) 0,171 0,117   −0,274 0,0126
Pyrilinks (nMPD/mMc)      
Osteocalcin (ng/ml) −0,391 0,0001    
L-BMD (g/cm2)     −0,319 0,0025
adjusted R2 0,408 0,00000 adjusted R2 0,251 0,0001
  1. PAI-1 plasminogen activator inhibitor 1, BMI body mass index, L-BMD lumbar bone mineral density